Q32 Bio (QTTB) Return on Capital Employed Growth (3y) (2021 - 2026)
Q32 Bio (QTTB) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Q32 Bio |
167.59 Mn |
116.84 Mn |
- |
2,605.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
2,605.00 |
| Dec 31, 2025 |
3,530.00 |
| Sep 30, 2025 |
-6,279.00 |
| Jun 30, 2025 |
-7,002.00 |
| Mar 31, 2025 |
-6,573.00 |
| Dec 31, 2024 |
-7,078.00 |
| Sep 30, 2024 |
-3,666.00 |
| Jun 30, 2024 |
-1,533.00 |
| Mar 31, 2024 |
-4,249.00 |
| Dec 31, 2023 |
-242.00 |
| Sep 30, 2023 |
11,403.00 |
| Jun 30, 2023 |
8,217.00 |
| Mar 31, 2023 |
5,806.00 |
| Dec 31, 2022 |
3,609.00 |
| Sep 30, 2022 |
1,092.00 |
| Jun 30, 2022 |
1,311.00 |
| Mar 31, 2022 |
901.00 |
| Dec 31, 2021 |
1,499.00 |
| Sep 30, 2021 |
-1,999.00 |
| Jun 30, 2021 |
-1,669.00 |
